This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Björn Lundahl Articles by Karpe, F. Search for Related Content PubMed PubMed Citation Articles by Björn Lundahl, Articles by Karpe, F. Related Collections Clinical genetics Lipids Other arteriosclerosis Genetics of cardiovascular disease

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:1784.)
© 2000 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

A Functional Polymorphism in the Promoter Region of the Microsomal Triglyceride Transfer Protein (MTP -493G/T) Influences Lipoprotein Phenotype in Familial Hypercholesterolemia

Björn Lundahl; Trond P. Leren; Leiv Ose; Anders Hamsten; Fredrik Karpe

From the Atherosclerosis Research Unit (B.L., A.H., F.K.), King Gustaf V Research Institute, Karolinska Hospital, Stockholm, Sweden; the Medical Genetics Laboratory (T.P.L.), Medinnova/MSD Cardiovascular Research Center, Rikshospitalet, Oslo, Norway; and the Lipid Clinic (L.O.), Medical Department A, Rikshospitalet, Oslo, Norway.

Correspondence to Björn Lundahl, Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Hospital, S-17176 Stockholm, Sweden. E-mail bjorn.lundahl{at}bigfoot.com

Abstract—The microsomal triglyceride transfer protein (MTP) has a key function in intracellular apolipoprotein (apo) B lipidation and secretion of very low density lipoprotein (VLDL). A recently discovered functional polymorphism in the promoter of the MTP gene (-493G/T) affects the plasma concentration of low density lipoprotein (LDL) cholesterol and the VLDL distribution between large and small particle species in healthy men. This phenotype is likely to be explained by an effect on VLDL synthesis. Against this background, we studied the effect of the MTP-493G/T polymorphism in a large cohort (217 men and 211 women) with heterozygous familial hypercholesterolemia (FH). A 40% to 50% lower serum triglyceride level was observed in homozygous carriers of the MTP-493 T allele (T/T, 0.93±0.34; G/T, 1.54±1.40; and G/G, 1.56±1.24 mmol/L; T/T vs G/T P=0.04, T/T vs G/G P=0.02). In contrast to the situation in healthy subjects, the MTP promoter polymorphism did not have a significant effect on the LDL cholesterol levels in FH subjects, although the same trend was observed (T/T, 7.31±1.87; G/T, 7.80±2.12; and G/G, 7.91±2.31 mmol/L, NS). Adjustment for the apo E gene polymorphism by inclusion of subjects homozygous for the apo E3 allele only revealed a reciprocal high density lipoprotein cholesterol–elevating effect (T/T, 1.41±0.73; G/T, 1.18±0.27; and G/G, 1.16±0.29 mmol/L; T/T vs G/T P=0.06, T/T vs G/G P=0.04). This effect seemed to be sex-specific because it was accounted for by the female patients. In conclusion, the LDL cholesterol–lowering effect of the rare MTP gene promoter variant (MTP-493T) present in healthy subjects is shifted to a triglyceride-lowering effect in FH. These data suggest that the MTP gene has a role in modulating the clinical phenotype of FH.

Key Words: polymorphisms • lipoproteins • promoter regions • microsomes • familial hypercholesterolemia

This article has been cited by other articles:

				M. J. Neville, R. Clarke, J. G. Evans, D. C. Rubinsztein, and F. Karpe Absence of Relationship Between MTTP Haplotypes and Longevity J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2007; 62(2): 202 - 205. [Abstract] [Full Text] [PDF]

				M. Beekman, G. J. Blauw, J. J. Houwing-Duistermaat, B. W. Brandt, R. G. J. Westendorp, and P. E. Slagboom Chromosome 4q25, microsomal transfer protein gene, and human longevity: novel data and a meta-analysis of association studies. J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2006; 61(4): 355 - 362. [Abstract] [Full Text] [PDF]

				B. Lundahl, C. Skoglund-Andersson, M. Caslake, D. Bedford, P. Stewart, A. Hamsten, C. J. Packard, and F. Karpe Microsomal triglyceride transfer protein -493T variant reduces IDL plus LDL apoB production and the plasma concentration of large LDL particles Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E739 - E745. [Abstract] [Full Text] [PDF]

				A Cenarro, M Artieda, S Castillo, P Mozas, G Reyes, D Tejedor, R Alonso, P Mata, M Pocovi, and F Civeira A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia J. Med. Genet., March 1, 2003; 40(3): 163 - 168. [Abstract] [Full Text] [PDF]

				M. C. Lin, E.-J. Wang, C. Lee, K.T. Chin, D. Liu, J.-F. Chiu, and H.-f. Kung Garlic Inhibits Microsomal Triglyceride Transfer Protein Gene Expression in Human Liver and Intestinal Cell Lines and in Rat Intestine J. Nutr., June 1, 2002; 132(6): 1165 - 1168. [Abstract] [Full Text] [PDF]

				H. Ledmyr, F. Karpe, B. Lundahl, M. McKinnon, C. Skoglund-Andersson, and E. Ehrenborg Variants of the microsomal triglyceride transfer protein gene are associated with plasma cholesterol levels and body mass index J. Lipid Res., January 1, 2002; 43(1): 51 - 58. [Abstract] [Full Text] [PDF]